Latest filing published 19 Nov 2024 for Skye Bioscience, Inc., €1,618.
Filing timeline
BuySaleInsider track record
No signal scores available.
Paul A. Grayson: trading record in brief
Paul A. Grayson appears in our data through filings on Skye Bioscience, Inc. shares, published by SEC (Form 4). We count 5 filings; the first trade dates from 25 August 2023 and the latest from 18 November 2024.
Sales make up the whole of the open-market record (2 sales, €410k). Besides market trades, the filings include 3 share grants. 2024 to date brings no purchases and 2 sales.
On 19 November 2024 came the latest disclosure, an open-market sale for €409k in Skye Bioscience, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Paul A. Grayson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 307 shares@ US$5.55100.0% of flowCommon StockSEC:0001516551-24-000114:0
- 100,000 shares0Common StockSEC:0001516551-24-000043:0
- 173,721 shares0Common StockSEC:0001516551-23-000093:0
- 18,132,596 sharesCommon StockSEC:0001516551-23-000066:0
4 of 4 declarations